Trial intelligence / Profile preview

Taste-masked CoPhenylcaine Forte for nasendoscopy

ACTRN12616001335482Phase 3Completed

Sponsor
Stuart Bailey
Start
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of lidocaine + phenylephrine in None (2 arms), sponsored by Stuart Bailey. Primary endpoints: Overall spray preference and Overall satisfaction rating. Started Feb 2016; status: completed.

02

Drugs

lidocaine + phenylephrine

Beyond the preview

Go deeper on ACTRN12616001335482.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12616001335482.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call